EXACT Sciences (NASDAQ:EXAS) Downgraded by Benchmark to Hold

Sigma Planning Corp decreased its position in shares of EXACT Sciences Co. "(NASDAQ:EXAS)" was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. More interesting news about Exact Sciences Corporation (NASDAQ:EXAS) were released by: Seekingalpha.com and their article: "Earnings Preview: Exact Sciences" published on February 19, 2018 as well as Marketwatch.com's news article titled: "Exact Sciences shares fall after beating Street estimates" with publication date: February 22, 2018. The firm's revenue for the quarter was up 148.0% compared to the same quarter last year. research analysts anticipate that EXACT Sciences Co. will post -0.84 EPS for the current year.

Analysts await Lam Research Corporation (NASDAQ:LRCX) to report earnings on April, 17.

Whereas they predicted High and Low Earnings Estimate as $-0.24 and $-0.41 respectively.

EXACT Sciences (NASDAQ:EXAS) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating in a research note issued to investors on Thursday, March 1st.

EXACT Sciences (NASDAQ:EXAS) last posted its quarterly earnings data on Thursday, February 22nd. The medical research company reported ($0.18) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.27) by $0.09. This estimate is provided by 12 analysts.

The Company now has ROA (Return on Assets) of 4.5 percent, Return on Equity (ROE) of 9.8 Percent and Return on Investment (ROI) of 1% with Gross margin of 53 percent and Operating & Profit margin of -9.8% and 32.3% respectively. The business had revenue of $87.41 million during the quarter, compared to the consensus estimate of $87.42 million. Last quarter, the company saw 72.57 million in total revenues. This ratio also gives some idea of whether you're paying too much for what would be left if the company went bankrupt immediately. Robert W. Baird cut shares of EXACT Sciences from an "outperform" rating to a "neutral" rating and set a $56.00 price objective for the company.in a research note on Monday, November 13th. Finally, Zacks Investment Research raised EXACT Sciences from a "hold" rating to a "buy" rating and set a $62.00 price target on the stock in a research note on Tuesday, January 16th. As per Zacks simplified descending rating scale the ABR rank is displayed in the range of 1 to 5 where 1 represents Strong Buy and 5 a Strong Sell.

Exact Sciences Corporation (EXAS) added 2.5% to reach $52.15 in the previous trading session. The company had a trading volume of 4,048,749 shares, compared to its average volume of 2,678,679. Sanctuary Wealth Advisors Llc who had been investing in Exact Sciences Corporation for a number of months, seems to be less bullish one the $6.31B market cap company. The company has a quick ratio of 6.77, a current ratio of 7.15 and a debt-to-equity ratio of 0.01. The shares were sold at an average price of $43.10, for a total value of $1,719,000.40.

Oil price rises towards $70 on reduced United States drilling activity
Energy Information Administration said output from the shale basin would hit a new record high in April. The country's light oil price was reported $65.43 on average since the beginning of 2018 until March 2.

Peter Algert decreased its stake in Arc Document Solutions Inc (ARC) by 57.41% based on its latest 2017Q3 regulatory filing with the SEC.

In related news, COO Maneesh Arora sold 12,352 shares of EXACT Sciences stock in a transaction that occurred on Monday, February 26th.

The PEG ratio is used to determine a stock's value while taking the company's earnings growth into account, and is considered to provide a more complete picture than the P/E. The disclosure for this sale can be found here.

The Stock had a 1.77 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.77 and 1.77 respectively. Hedge funds and other institutional investors own 81.10% of the company's stock. Salem Investment Counselors Inc. increased its stake in shares of EXACT Sciences by 548.0% during the fourth quarter. Riverhead Capital Management Ltd Com holds 33,800 shares. Doheny Asset Management CA bought a new stake in shares of EXACT Sciences during the fourth quarter worth $2,345,000. Following the sale, the senior vice president now directly owns 37,558 shares in the company, valued at $1,973,297.32. The institutional investor owned 923,704 shares of the medical research company's stock after selling 41,646 shares during the period. Salem Investment Counselors Inc. now owns 6,480 shares of the medical research company's stock valued at $340,000 after buying an additional 5,480 shares during the period. Finally, MetLife Investment Advisors LLC purchased a new position in shares of EXACT Sciences during the fourth quarter valued at approximately $2,855,000. Company insiders own 4.00% of the company's stock.

WARNING: This piece of content was reported by BBNS and is owned by of BBNS. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and worldwide copyright and trademark law. The legal version of this news story can be read at https://weekherald.com/2018/03/12/green-valley-investors-llc-cuts-holdings-in-exact-sciences-co-exas.html. Exact Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since March 11, 2017 and is uptrending. The Company focuses on the early detection and prevention of some forms of cancer.

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population.



Latest news

It Looks Like Another Magnetic Storm is Coming Our Way
NOAA's 27-day forecast suggests similar fluctuations, expected to be "a minor storm at most", according to Newsweek . These solar storms are accounted based on a scale of G1 to G5 where G1 is a weak/minor solar activity.

Stocks on the Move: Bunge Limited (BG), Archer-Daniels-Midland Company (ADM)
It dived, as 112 investors sold GE shares while 818 reduced holdings. 118 funds opened positions while 525 raised stakes. The company reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.70 by $0.12.

NASS says Senators receiving N13.5m is old news
The sum is said to be illegal as it is not approved by the Revenue Mobilisation Allocation and Fiscal Commission (RMAFC ).

Hillary Clinton arrives in Rajasthan
The former U.S. secretary of state is in Maheshwar at the invitation of Richard Holkar, scion of the erstwhile Holkar kingdom. When she was asked if Trump deserved to be the President of United States, she said, "No, we did not deserve that".

Siale Angilau Shot In Courtroom After Attacking Witness
He was the last defendant in the case to stand trial, with previous defendants being sentenced to 10 to 30 years in prison. Faces of nearly all the people present inside the courtroom at the time, including the judge is blurred in the video.

Five candidates from Telangana file nominations for Rajya Sabha
Santosh is the nephew of the chief minister while the other two are from the OBC communities. Voting will be necessary in Telangana if the Congress does not withdraw its candidate.

Chancellor Philip Hammond delivers Spring Statement
Growth forecasts in 2019 and 2020 were 1.3 percent for both years, unchanged from the November forecast. He also announced estimates from the Office for Budget Responsibility that jobs growth would continue.

The Kimberly Clark (KMB) Given Daily Media Sentiment Rating of 0.17
With 150,600 avg volume, 0 days are for Aytu Bioscience Inc (NASDAQ:AYTU)'s short sellers to cover AYTU's short positions. TrovaGene, Inc. (TROV) has declined 83.95% since March 11, 2017 and is downtrending. (NASDAQ:MU) or 360,200 shares.

Sukma: Names of 9 CRPF Personnel Martyred in IED Blast
The personnel were onboard a mine protection vehicle which was passing through Kistaram, a naxal-dominated part of Sukma district. Chhattisgarh chief minister Raman Singh said that he was "overwhelmed with grief" with the loss of the nine officials.

California State Teachers Retirement System Raises Holdings in Accenture Plc
It turned negative, as 40 investors sold ACN shares while 370 reduced holdings. 49 funds opened positions while 111 raised stakes. British Columbia Investment Management Corp sold 64,530 shares as Accenture Plc Ireland (ACN)'s stock declined 0.21%.

Matteo Renzi formally resigns as Democratic Party leader
Italian media speculation is growing that the only way out of the parliamentary deadlock maybe a national unity government backed by all the main parties.

Fifth Third Bancorp Has Increased Holding in Celgene Corp (CELG)
Lombard Odier Asset Management (Switzerland) Sa reported 102,949 shares. 44,562 were reported by Dixon Hubard Feinour & Brown Va. The United Kingdom-based Marshall Wace Ltd Liability Partnership has invested 0.08% in Celgene Corporation (NASDAQ:CELG).

Chinese takeaways are so salty they need health warning
Too much salt can raise your blood pressure, which puts you at increased risk of health problems such as heart disease and stroke. And out of 141 Chinese ready meals at top United Kingdom supermarkets tested by researchers, 43% were high in salt.

Copper miner Antofagasta nearly triples dividend after profits jump
The FTSE 100 company will pay 50.9 USA cents a share, or 67pc of its underlying earnings - well above its 35pc threshold. Before exceptional items, basic earnings per share from continuing operations was 76.1 cents compared to 34.7 cents.

Investec Asset Management LTD Trims Stake in Mondelez International Inc (NASDAQ:MDLZ)
RBC Capital Markets maintained Mondelez International, Inc. (NASDAQ:MDLZ) has "Buy" rating given on Wednesday, February 24 by UBS. On Thursday, August 6 the stock rating was downgraded by Credit Agricole to "Outperform". (NASDAQ:AMZN) on Thursday, February 15.

Other news